symbol,name,description,country,year,period,documentUrl,income,expenses,postedName,date,clientId,registrantId,senateId,houseRegistrantId
IGMS,"IGM BIOSCIENCES, INC.",Development of engineered IgM antibodies,US,2022,Q2,https://lda.senate.gov/filings/public/filing/7ec15ad5-15f0-4a40-ae7b-8e2132c9bfe7/print/,10000,,,,209410,60550,60550-209410,35365
IGMS,"IGM BIOSCIENCES, INC.",Development of engineered IgM antibodies,US,2022,Q3,https://lda.senate.gov/filings/public/filing/5c4c7f7f-2b96-4fe0-baff-66dd2bc5eda3/print/,10000,,,,209410,60550,60550-209410,35365
IGMS,"IGM BIOSCIENCES, INC.",Development of engineered IgM antibodies,US,2022,Q4,https://lda.senate.gov/filings/public/filing/801f39d4-8d9a-4c6b-8935-3f7e4d27aaf6/print/,10000,,,,209410,60550,60550-209410,35365
IGMS,"IGM BIOSCIENCES, INC.",,US,2022,Q2,https://lda.senate.gov/filings/public/filing/35170c67-2b1f-4973-8d6a-a24fa200ad40/print/,,130000,,,212724,401106312,401106312-212724,401106312
IGMS,"IGM BIOSCIENCES, INC.",,US,2022,Q3,https://lda.senate.gov/filings/public/filing/8f1a2165-2ff6-44c5-833d-11f3e6316d95/print/,,190000,,,212724,401106312,401106312-212724,401106312
IGMS,"IGM BIOSCIENCES, INC.",,US,2022,Q4,https://lda.senate.gov/filings/public/filing/6659f7da-41a7-4dd6-8d91-7b2454f0bf96/print/,,210000,,,212724,401106312,401106312-212724,401106312
